How Mobocertinib can Save You Time, Stress, and Money.
Pharmacological inhibition of the ataxia telangiectasia and Rad3-similar protein serine/threonine kinase (ATR; also known as FRAP-connected protein (FRP1)) has emerged as a promising tactic for cancer treatment method that exploits artificial lethal interactions with proteins associated with DNA hurt repair, overcomes resistance to other therapies